Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ruediger Spitz"'
Autor:
A A Hombach, Benedikt Brors, Thorsten Simon, Ruth Volland, Barbara Hero, Matthias Fischer, Frank Berthold, Ruediger Spitz, Marc Zapatka, Monika Ortmann, André Oberthuer, Jessica Theissen, Falk Hertwig
Publikováno v:
Genes, Chromosomes and Cancer. 53:639-649
The prognostic relevance of chromosome 17 gain in neuroblastoma is still discussed. This investigation specifies the frequency, type, size, and transcriptional relevance in a large patient cohort. Primary tumor material of 202 patients was analyzed u
Publikováno v:
Clinical Cancer Research. 12:3368-3373
Purpose: To improve risk prediction in neuroblastoma and to specify the type of a possible relapse, alterations in the long arm of chromosome 11 were analyzed. Experimental Design: A representative cohort of 611 neuroblastomas was investigated for de
Autor:
Marc Boensch, André Oberthuer, Matthias Skowron, Ruediger Spitz, Matthias Fischer, Joern Oestreich, Frank Berthold
Publikováno v:
Diagnostic Molecular Pathology. 14:177-182
Amplification of the oncogene MYCN as well as deletions in 1p and 11q are important prognostic and in part therapy-stratifying factors in human neuroblastoma. Due to the increasing clinical relevance of these molecular markers, accurate and fast asse
Autor:
Karen Ernestus, Ruediger Spitz, Manfred Schwab, Frank Westermann, Frank Berthold, Barbara Hero
Publikováno v:
Genes, Chromosomes and Cancer. 34:299-305
Chromosomal alterations in 1p36 were investigated in 196 neuroblastoma tumors using fluorescence in situ hybridization. Additionally, by using the same technique, it was determined whether MYCN was amplified in 149 of these. The most frequent finding
Autor:
Jessica, Theissen, Andre, Oberthuer, Anja, Hombach, Ruth, Volland, Falk, Hertwig, Matthias, Fischer, Ruediger, Spitz, Marc, Zapatka, Benedikt, Brors, Monika, Ortmann, Thorsten, Simon, Barbara, Hero, Frank, Berthold
Publikováno v:
Genes, chromosomescancer. 53(8)
The prognostic relevance of chromosome 17 gain in neuroblastoma is still discussed. This investigation specifies the frequency, type, size, and transcriptional relevance in a large patient cohort. Primary tumor material of 202 patients was analyzed u
Autor:
A Hombach, Barbara Hero, Frank Berthold, J Theißen, M Fischer, Ruediger Spitz, André Oberthuer
Publikováno v:
Klinische Pädiatrie. 222
Autor:
Tobias Bauer, Benedikt Brors, Rainer König, Roland Eils, M Fischer, Frank Westermann, Frank Berthold, Ruediger Spitz, Barbara Hero, Andre Oberthur, Mathias Ehrich, Jessica Theissen
Publikováno v:
Oncogene. 29(6)
Imbalances in chromosome 11q occur in approximately 30% of primary neuroblastoma and are associated with poor outcome. It has been suggested that 11q loss constitutes a distinct clinico-genetic neuroblastoma subgroup by affecting expression levels of
Autor:
Manfred Schwab, Holger Christiansen, Frank Berthold, Felix Niggli, Frank Westermann, David R. Betts, Barbara Hero, Thorsten Simon, Freimut H. Schilling, Jessica Theissen, Sabine Stegmaier, Marc Boensch, Ruediger Spitz
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(6)
Purpose: MYCN amplification is an important therapy-stratifying marker in neuroblastoma. Fluorescence in situ hybridization with signal detection on the single-cell level allows a critical judgement of MYCN intratumoral heterogeneity. Experimental De
Publikováno v:
Klinische Padiatrie. 220(3)
The pediatric tumor neuroblastoma is a heterogeneous disease: Patients' clinical courses can range from spontaneous regression to fatal progression of the disease. Accordingly, treatment protocols vary from "wait and see" approaches to intensive mult
Autor:
Astrid Gnekow, Karen Ernestus, Ruediger Spitz, Frank Berthold, Hans-Guenther Scheel-Walter, Dirk Schwabe, Freimut H. Schilling, Barbara Hero, Gabriele Benz-Bohm, Thorsten Simon
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(9)
Purpose The excellent prognosis of localized neuroblastoma in infants, the overdiagnosis observed in neuroblastoma screening studies, and several case reports of regression of localized neuroblastoma prompted us to initiate a prospective cooperative